Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHAMP: Cholinergic System and AD Risk in Postmenopausal Women
NCT04129060Phase 1Completed
- Sponsor
- The University of Vermont
- Start
- Mar 2020
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing Mecamylamine Challenge with Placebo Challenge (2 arms). Primary endpoints: Blood Oxygen Dependent Functional Magnetic Resonance Imaging, Working Memory Performance and 1 more. Started Mar 2020; status: completed.
02
Drugs
mecamylamine
Beyond the preview
Go deeper on NCT04129060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04129060.